ARCHIVES

Clolar Approved for Pediatric Refractory/Relapsed ALL

This article is from The Cancer Letter archive.

Vol. 28 No. 1 | January 28, 2005

Download PDF Visit The Full Archive

Related Articles

Benefits of Mammography Outweigh Harms In Women with Increased Risk, Starting at Age 40

April 27, 2012

Complete List of Recommendations by Centers Committee

October 18, 1996

NCI to Close Clinical Branch at Frederick, Move Patients, Protocols To Bethesda

May 17, 1996

Texas Oncology Designated Aranesp As Preferred Treatment

December 13, 2002

DCE Advisors Approve New Epidemiology RFPs Table Proposed RFA

April 16, 1993

Sullivan Confirmation Hearing Set For Feb. 1

January 27, 1989